Abbott in India develops and distributes over 600 products for healthcare professionals that promote health and well-being for Indians in all stages of life. Search by all products, business area or pharmaceutical therapy area below
ICIKINASE 1.5 MIU
Business: Abbott Healthcare Solutions
MOLECULE: R-Streptokinase
FORM: Injection
STRENGTH: R-Streptokinase of 1,500,000 IU
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Cardio-diabeto
ICUPEN 500
Business: Abbott Healthcare Solutions
MOLECULE: Doripenem Monohydrate
FORM: Injection
STRENGTH: 500 mg
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Anti-Infectives
ICUstin 1 M IU
Business: Abbott Healthcare Solutions
MOLECULE: Colistimethate Sodium
FORM: Injection
STRENGTH: Colistimethate Sodium BP 10,00,000 IU (IU: International Units), 1 Million IU / vial Lyophilized Injection for I.V.
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Anti-Infectives
IMDx
IME - CILA 250
MOLECULE: Imipenem and Cilastatin
FORM: Injection
STRENGTH: Imipenem 250 (?) + Cilastatin 250 (?)
BUSINESS AREAS: Pharmaceuticals
IME - CILA 500
MOLECULE: Imipenem and Cilastatin
FORM: Injection
STRENGTH: Imipenem 500 (?) + Cilastatin 500 (?)
BUSINESS AREAS: Pharmaceuticals
ISMO Retard
Business: Abbott Healthcare Solutions
MOLECULE: Diluted Isosorbide Mononitrate IP
FORM: Tablet
STRENGTH: 40 mg
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Cardio-diabeto
ISMO
Business: Abbott Healthcare Solutions
MOLECULE: Diluted Isosorbide Mononitrate IP
FORM: Tablet
STRENGTH: 10 mg, 20 mg
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Cardio-diabeto
Icustin 2 M IU
Business: Abbott Healthcare Solutions
MOLECULE: Colistimethate Sodium
FORM: Injection
STRENGTH: Colistimethate Sodium BP 20,00,000 IU (IU: International Units), 1 Million IU / vial Lyophilized Injection for I.V.
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Anti-Infectives
Immunoassay Chemistry Tests
Imumax
Business: Abbott Healthcare Solutions
MOLECULE: rHu-GCSF
FORM: Injection
STRENGTH: rHu-GCSF 300 MCG/ML
BUSINESS AREAS: Pharmaceuticals
Imupeg
Business: Abbott Healthcare Solutions
MOLECULE: PEG-GCSF
FORM: Injection
STRENGTH: PEG-GCSF 6 MG/0.6ML
BUSINESS AREAS: Pharmaceuticals
Inderal La
Business: Abbott India Limited
MOLECULE: Propranolol Hydrochloride
FORM: Tablet
STRENGTH: 20 MG,40 MG
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Neuroscience
THERAPY AREAS: Neuroscience
Inderal
Business: Abbott India Limited
MOLECULE: Propranolol Hydrochloride
FORM: Tablet
STRENGTH: 10 mg; 40 mg
BUSINESS AREAS: Pharmaceuticals,PHARMACEUTICALS ABBOTT INDIA LIMITED,Neuroscience
THERAPY AREAS: Neuro-Psychiat,Neuroscience
Influvac 2014
Business: Abbott India Limited
MOLECULE: A/California/7/2009 (H1N1)pdm09, A/Texas/50/2012 (H3N2), B/Massachusetts/2/2012
FORM: Injection
STRENGTH: 0.5 ml prefilled syringe
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Vaccine
Influvac Jr
Business: Abbott India Limited
MOLECULE: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181)+ A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) + B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type)
FORM: Pre filled Syringe
STRENGTH: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181) 7.5 mcg HA, A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) 7.5 mcg HA, B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type) 7.5 mcg HA per 0.25 mL dose. This vaccine complies with the WHO recommendation (northern hemisphere) and competent authority decision for the 2016/2017 season.
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine
THERAPY AREAS: Vaccine
Influvac
Business: Abbott India Limited
MOLECULE: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181)+ A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) + B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type)
FORM: Pre Filled Syringe
STRENGTH: Influenza virus surface antigens (hemagglutinin and neuraminidase) of the following strains (propagated in fertilized hens' eggs from healthy chicken flocks) A/California/7/2009 (H1N1)pdm09-like strain (A/California/ 7/2009, X-181) 15 mcg HA, A/Hong Kong/4801/2014 (H3N2)-like strain (A/New Caledonia/71/2014, X-257A) 15 mcg HA, B/Brisbane/60/2008-like strain(B/Brisbane/60/2008, wild type) 15 mcg HA per 0.5 mL dose. This vaccine complies with the WHO recommendation (northern hemisphere) and competent authority decision for the 2016/2017 season.
BUSINESS AREAS: PHARMACEUTICALS ABBOTT INDIA LIMITED,Vaccine
THERAPY AREAS: Vaccine
Informatics Solutions
IntraLase
ItraLase FS Laser
Ivabid
Business: Abbott Healthcare Solutions
MOLECULE: Ivabradine
FORM: Tablet
STRENGTH: 5 mg, 7.5 mg
BUSINESS AREAS: Pharmaceuticals
THERAPY AREAS: Cardio-diabeto
i-STAT System
i-STAT® 1 Wireless
iFS™ Advanced Femtosecond Laser
iLasik
accordion
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
FOLLOW ABBOTT